Market closed

iRadimed/$IRMD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About iRadimed

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Ticker

$IRMD
Trading on

Industry

Health Care Equipment & Supplies

Employees

148

iRadimed Metrics

BasicAdvanced
$660M
Market cap
35.67
P/E ratio
$1.46
EPS
0.81
Beta
$0.93
Dividend rate
1.15%
Dividend yield
$660M
0.81
$56.32
$40.05
37K
$0.93
9.213
6.415
0.003
0.003
63.22%
14.67%
23.58%
35.672
9.242
7.91
8.19
38.412
1.79%
1.15%
13.23%
13.16%
22.82%
44.88%

What the Analysts think about iRadimed

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for iRadimed stock.

iRadimed Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

iRadimed Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IRMD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Nov
25
iRadimed
Dividend·Payment
$0.15
Per share

FAQs

What’s the current market cap for iRadimed stock?

iRadimed (IRMD) has a market cap of $660M as of November 22, 2024.

What is the P/E ratio for iRadimed stock?

The price to earnings (P/E) ratio for iRadimed (IRMD) stock is 35.67 as of November 22, 2024.

Does iRadimed stock pay dividends?

Yes, the iRadimed (IRMD) stock pays dividends to shareholders. As of November 22, 2024, the dividend rate is $0.93 and the yield is 1.15%. iRadimed has a payout ratio of 63.22% on a trailing twelve-month basis.

When is the next iRadimed dividend payment date?

The next iRadimed (IRMD) dividend payment is scheduled for November 25, 2024.

What is the beta indicator for iRadimed?

iRadimed (IRMD) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.